文献速递肝胆胰外科围术期管理与 ERAS

ACS-NSQIP中心14年胰腺恶性肿瘤手术:主要并发症与死亡率趋势

Fourteen years of pancreatic surgery for malignancy among ACS-NSQIP centers: Trends in major morbidity and mortality.
PubMed 文献 · Surgery · 2022-05-07

远端胰腺切除术后主要并发症与死亡率无显著变化。

要点

  • 远端胰腺切除术后主要并发症与死亡率均无显著变化。
  • 胰十二指肠切除术后器官腔隙感染和静脉血栓栓塞年增3.52%和4.72%。

核心结论

  • 胰十二指肠切除术后死亡率持续下降但主要并发症增加,远端胰腺切除术后两者无显著变化。

研究设计与样本

  • 回顾性队列研究,纳入ACS-NSQIP数据库2006-2019年28,888例胰腺恶性肿瘤切除患者。

临床怎么用

  • 胰腺恶性肿瘤切除术后需关注胰十二指肠切除患者主要并发症增加趋势,尤其是器官腔隙感染和静脉血栓栓塞。

局限性

  • 趋势是否反映患者选择变化、并发症检出增加或处理改善有待进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The American College of Surgeons National Surgical Quality Improvement Program was established to help participating hospitals track and report surgical complications with the goal of improving surgical care. We sought to determine whether this has led to improvements in surgical outcomes for pancreatic malignancies. METHODS: Patients with pancreatic malignancies who underwent surgical resection were identified from the American College of Surgeons National Surgical Quality Improvement Program database (2006-2019). Thirty-day postoperative major morbidity and mortality were analyzed by year. Major morbidity included organ and deep surgical site infection, venous thromboembolism, cardiac event, pneumonia, acute renal failure, sepsis, and respiratory failure. RESULTS: Of the 28,888 patients identified, 51% were male, the median age was 68, 74.3% underwent a pancreaticoduodenectomy, and 25.7% underwent a distal pancreatectomy. Among patients who underwent a pancreaticoduodenectomy, there was a significant increase in major morbidity (annual percent change 0.77, P = .012) driven by increases in organ space surgical site infection (annual percent change 3.52, P < .001) and venous thromboembolism (annual percent change 4.72, P = .005). However, there was a decrease in postoperative mortality (annual percent change -4.58, P = .001). For distal pancreatectomy patients, there was no change in rates of overall major morbidity (annual percent change -1.35, P = .08) or mortality (annual percent change -3.21, P = .25). CONCLUSION: Although major morbidity and mortality have not significantly changed for distal pancreatectomy patients, mortality has steadily decreased for patients undergoing pancreaticoduodenectomy, despite an increase in major morbidity. Whether this trend reflects a change in patient selection, an increase in detection of postoperative morbidities and/or an improvement in mitigation of these morbidities warrants further study.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Sharon CE, Thaler AS, Straker RJ, et al. Fourteen years of pancreatic surgery for malignancy among ACS-NSQIP centers: Trends in major morbidity and mortality. Surgery. 2022. PMID: 35537881. doi:10.1016/j.surg.2022.03.030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。